BeiGene Ltd ADR (NASDAQ:ONC) does about 360.02K shares in volume on a normal day but saw 472726 shares change hands in the recent trading day. The company now has a market cap of 20.53B USD. Its current market price is $210.08, marking an increase of 2.31% compared to the previous close of $205.34. The 52 week high reached by this stock is $248.16 whilst the lowest price level in 52 weeks is $126.97.
BeiGene Ltd ADR (ONC) has a 20-day trading average at $184.97 and the current price is -15.34% off the 52-week high compared with 65.46% distance from its 52-week low. The 50-day simple moving average of the closing price is $191.40 and its 200-day simple moving average is $180.33. If we look at the stock’s price movements over the week, volatility stands at 4.90%, which decreases to 3.14% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 69.22 to suggest the stock is neutral.
The consensus objective for the share price is $287.72, suggesting that the stock has a potential upside of 26.98% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on December 03, 2024 when Morgan Stanley resumed the stock to “Overweight” and issued a price target of $300. JP Morgan resumed its price target at $185.
The current price level is 13.58%, 9.76%, and 16.50% away from its SMA20, SMA50, and SMA200 respectively, with the ONC price moving above the 50-day SMA on current market day. BeiGene Ltd ADR (ONC) stock is up 18.88% over the week and 19.14% over the past month. Its price is 13.74% year-to-date and 25.20% over the past year.
To reach the target analysts have set, the stock logically needs to grow 26.98 percent from here.
The company has a return on investment of -23.54% and return on equity of -23.90%. The beta has a value of 0.62. Price to book ratio is 6.52 and price to sales ratio is 6.19.
